|
at 10:10 |
|
|
HighField Biopharmaceuticals, a clinical stage immuno-oncology company using lipid-based therapeutics to treat cancer, announced today that two HighField abstracts have been accepted with one poster presentation at the American Society of Clinical...
|
|
at 10:10 |
|
|
Bicycle Therapeutics plc , a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the acceptance of two abstracts for poster presentation...
|
|
at 10:07 |
|
|
W.W. Grainger, Inc. announced today that its board of directors approved a quarterly cash dividend of $2.05 per share, an increase of 10% from the most recent company dividend. The dividend is payable on June 1, 2024, to shareholders of record on...
|
|
at 10:05 |
|
|
Udemy , a leading online skills marketplace and learning platform, today released its Q1 2024 Global Workplace Learning Index, a quarterly report highlighting in-demand skills that help companies remain competitive in a fast-changing global economy....
|
|
at 10:05 |
|
|
RouteSmart Technologies will be unveiling RouteSmart for ArcGIS Pro, a revolutionary solution designed to transform snowplow operations, at the APWA North American Snow Show.
This advanced solution leverages sophisticated algorithms to address the...
|
|
at 10:05 |
|
|
Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced two presentations, including an oral presentation on the Phase 1 first-in-human study of OBX-115, a novel engineered...
|
|
|
